GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DMS Imaging SA (XBRU:ALIMG) » Definitions » Net Margin %

DMS Imaging (XBRU:ALIMG) Net Margin % : -7.26% (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is DMS Imaging Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. DMS Imaging's Net Income for the six months ended in Dec. 2023 was €-1.43 Mil. DMS Imaging's Revenue for the six months ended in Dec. 2023 was €19.75 Mil. Therefore, DMS Imaging's net margin for the quarter that ended in Dec. 2023 was -7.26%.

The historical rank and industry rank for DMS Imaging's Net Margin % or its related term are showing as below:

XBRU:ALIMG' s Net Margin % Range Over the Past 10 Years
Min: -192875   Med: -15.81   Max: -0.66
Current: -1.75


XBRU:ALIMG's Net Margin % is ranked better than
74.83% of 1029 companies
in the Biotechnology industry
Industry Median: -157.22 vs XBRU:ALIMG: -1.75

DMS Imaging Net Margin % Historical Data

The historical data trend for DMS Imaging's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DMS Imaging Net Margin % Chart

DMS Imaging Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -0.66 -15.81 -1.75

DMS Imaging Semi-Annual Data
Dec13 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.39 -22.02 -9.19 3.48 -7.26

Competitive Comparison of DMS Imaging's Net Margin %

For the Biotechnology subindustry, DMS Imaging's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DMS Imaging's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DMS Imaging's Net Margin % distribution charts can be found below:

* The bar in red indicates where DMS Imaging's Net Margin % falls into.



DMS Imaging Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

DMS Imaging's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-0.709/40.564
=-1.75 %

DMS Imaging's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-1.434/19.748
=-7.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DMS Imaging  (XBRU:ALIMG) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


DMS Imaging Net Margin % Related Terms

Thank you for viewing the detailed overview of DMS Imaging's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


DMS Imaging (XBRU:ALIMG) Business Description

Traded in Other Exchanges
Address
7 Rue des Chasseurs Ardennais, Liege, BEL, 4031
DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.

DMS Imaging (XBRU:ALIMG) Headlines

No Headlines